Hobbs Group Advisors LLC Sells 107 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hobbs Group Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 15.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 598 shares of the healthcare conglomerate’s stock after selling 107 shares during the quarter. Hobbs Group Advisors LLC’s holdings in UnitedHealth Group were worth $302,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. M&T Bank Corp grew its position in shares of UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC increased its position in UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. grew its position in UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after acquiring an additional 41,308 shares during the last quarter. Parsifal Capital Management LP acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $21,165,000. Finally, Signal Advisors Wealth LLC lifted its holdings in shares of UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the period. 87.86% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Price Performance

UNH opened at $515.47 on Friday. The firm has a market cap of $471.51 billion, a PE ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a 50-day moving average price of $508.81 and a 200-day moving average price of $544.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $5.83 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on UNH. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Finally, Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.